Research and Markets: Advancements in Prenatal Screening Trends

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mqg2ql/advancements_in) has announced the addition of the "Advancements in Prenatal Screening Trends" report to their offering.

The report illustrates the advancements in Prenatal Screening with a brief note on emerging developments in non-invasive prenatal screening, emerging developments in non-invasive prenatal testing, and emerging trends in the US non-invasive prenatal screening market. Prenatal diagnosis enables detection of chromosomal abnormalities and genetic mutations in human fetus, or embryo, at very early stage of pregnancy, including chromosome anomalies, neural tube defects, genetic abnormalities, Down's syndrome (trisomy 21 condition), and other conditions.

In addition the report also highlights the role of the obstetricians, physicians and genetic counselors in helping the expectant mothers to arrive at an informed decision concerning prenatal screening.

Key Topics Covered:

1. ADVANCEMENTS IN PRENATAL SCREENING - A FOCUS REPORT

Prenatal Diagnosis - A Prelude

2. MARKET INFORMATION

Prenatal Screening Market Poised for Growth

Emerging Developments in Non-Invasive Prenatal Screening

Emerging Developments in Non-Invasive Prenatal Testing

Emerging Trends in the US Non-Invasive Prenatal Screening Market

Options Available for Prenatal Diagnostics

Emerging Developments in Prenatal Diagnostics Market

3. PRENATAL DIAGNOSIS - AN OVERVIEW

Screening Test vis-à-vis Diagnostic Test

Purpose of Prenatal Diagnosis

Conditions Specifically Tested for During Prenatal Diagnosis

Efficacy of Prenatal Screening

Negative Versus Positive Screens

Health Information Critical for Expectant Mothers

Neural Tube (NT) Abnormality and Chromosomal Anomaly

4. PRENATAL SCREENING - GUIDELINES & PROCEDURES

Prenatal Testing Decisions - Role of Physicians and Genetic Counselors

Testing Procedures for Prenatal Diagnosis

Maternal Serum Screening Cornerstone for Prenatal Diagnosis Triple Tests and Quadruple Screen

Fetal Aneuploidy Screening

5. EMERGING DEVELOPMENTS IN PRENATAL SCREENING TECHNOLOGIES

Emerging Screening Technologies

Prenatal Screening for Trisomy 21 Condition

Maternal Blood Sampling

Fetal DNA - Abnormality Testing

Genetic Profiling for Family Planning

Developments in Nasal Bone Analysis

6. NOTEWORTHY MARKET PARTICIPANTS

Ariosa Diagnostics, Inc. (USA)

Natera, Inc. (USA)

PerkinElmer, Inc. (USA)

7. CORPORATE INITIATIVES

BGI Pens an Agreement with GENNET

Illumina Takes Over BlueGnome

8. PRODUCT LAUNCHES/TECHNOLOGY INNOVATIONS

9. APPENDIX

For more information visit http://www.researchandmarkets.com/research/mqg2ql/advancements_in

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics